IRIS
CASSANO, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.022
EU - Europa 3.843
AS - Asia 3.350
SA - Sud America 455
Continente sconosciuto - Info sul continente non disponibili 440
AF - Africa 64
OC - Oceania 3
Totale 13.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.936
CN - Cina 1.145
SG - Singapore 1.132
IE - Irlanda 941
UA - Ucraina 635
RU - Federazione Russa 552
SE - Svezia 437
IT - Italia 407
BR - Brasile 373
HK - Hong Kong 304
FR - Francia 274
DE - Germania 226
VN - Vietnam 196
IN - India 191
FI - Finlandia 129
TR - Turchia 123
KR - Corea 80
GB - Regno Unito 79
AT - Austria 44
BD - Bangladesh 34
CA - Canada 33
MX - Messico 26
AR - Argentina 23
ID - Indonesia 22
NL - Olanda 20
PL - Polonia 20
IQ - Iraq 19
JP - Giappone 17
ZA - Sudafrica 17
BE - Belgio 16
EC - Ecuador 13
MA - Marocco 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
CL - Cile 9
CO - Colombia 9
EU - Europa 8
LT - Lituania 8
PK - Pakistan 8
PY - Paraguay 8
SA - Arabia Saudita 8
VE - Venezuela 8
CH - Svizzera 6
CR - Costa Rica 6
ES - Italia 6
BH - Bahrain 5
HN - Honduras 5
KE - Kenya 5
PE - Perù 5
PT - Portogallo 5
TN - Tunisia 5
DK - Danimarca 4
DZ - Algeria 4
GR - Grecia 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
TH - Thailandia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SN - Senegal 3
BO - Bolivia 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
TV - Tuvalu 2
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NC - Nuova Caledonia 1
Totale 12.734
Salva come PNG Salva come JPEG
Città #
Dublin 939
San Jose 809
Singapore 610
Chandler 536
Jacksonville 429
Dearborn 325
Ashburn 316
Hong Kong 303
Nyköping 291
Beijing 275
Nanjing 205
Dallas 195
Santa Clara 144
Council Bluffs 122
Lauterbourg 104
Wilmington 104
Princeton 98
New York 92
Columbus 85
The Dalles 84
Nanchang 71
Ann Arbor 70
Moscow 63
San Mateo 63
Ho Chi Minh City 60
Helsinki 56
Los Angeles 55
Boardman 50
Des Moines 49
Rome 48
Shenyang 47
Munich 45
Hebei 44
Tianjin 39
Hilden 36
Hanoi 35
Woodbridge 33
Jiaxing 32
São Paulo 31
Foggia 30
Kunming 30
Vienna 30
Pune 29
Hangzhou 28
Jinan 28
Guangzhou 27
Bari 24
Seattle 19
Changsha 18
Milan 18
Ningbo 17
Brooklyn 16
Brussels 16
Warsaw 16
Chicago 15
Frankfurt am Main 15
Wuhan 15
Shanghai 14
Zhengzhou 14
Chennai 13
Haiphong 13
Dong Ket 12
Falls Church 12
Norwalk 12
Rio de Janeiro 12
San Severo 12
Tashkent 12
Tokyo 12
Washington 11
Atlanta 10
Düsseldorf 10
Jakarta 10
Lanzhou 10
San Francisco 10
Toronto 10
Auburn Hills 9
Denver 9
Houston 9
Johannesburg 9
Orem 9
Phoenix 9
West Jordan 9
Naples 8
New Delhi 8
Porto Alegre 8
Redwood City 8
Boston 7
Da Nang 7
Hefei 7
Nuremberg 7
Philadelphia 7
Santeramo In Colle 7
Stockholm 7
Amsterdam 6
Ankara 6
Baghdad 6
Biên Hòa 6
Curitiba 6
Dhaka 6
Falkenstein 6
Totale 7.779
Salva come PNG Salva come JPEG
Nome #
Use of mammalian target of rapamycin inhibitor for treating pathologies including neurodegenerative diseases (Alzheimer's disease), neuroinflammatory diseases and tumor diseases with neurological involvement, by intrathecal administration 213
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in wistar rats. 171
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 168
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 163
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 161
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 161
Biochemical and Neurobehavioral Profile of CHF2819, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease 160
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 156
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 154
Antinutritional effects of fumonisin B1 and pathophysiological consequences 152
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 151
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 151
Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels 150
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 148
Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects 148
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 146
Aberrant insulin signaling in Alzheimer's disease: current knowledge 146
Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats 144
Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration 144
Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. 142
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex 141
Novel codrugs with GABAergic activity for dopamine delivery in the brain 140
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 139
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 139
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles 137
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease 137
Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target 137
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 136
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 133
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder 132
CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor 131
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons 130
Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. 129
Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor 129
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 129
Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring 128
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 128
Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice 128
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 127
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 126
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 126
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease 126
Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence [Biomed. Pharmacother. 188 (2025) 118199] 125
Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring 125
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease: In Vitro and In Vivo Evidence 124
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs 123
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 122
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress 119
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 118
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 117
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. 116
Astrocyte function is affected by aging and not Alzheimer's disease: A preliminary investigation in hippocampi of 3xTg-AD mice 116
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress 115
Olfactory memory is impaired in a triple transgenic model of Alzheimer disease 115
Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients 115
Prenatal Exposure to the CB1 Receptor Agonist Win 55,212-2 Causes Learning Disruption Associated With Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring 114
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures 114
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 114
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm 114
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 114
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 111
Role of the area postrema in the hypophagic effects of oleoylethanolamide 111
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 110
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 108
Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide 108
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 107
Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide 107
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: An in vivo study 106
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 106
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 106
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge-eating disorder 105
Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats 104
Delta9-Tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons. Involvement of CB1 receptors 103
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 103
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard 103
Lung histopathological findings in COVID-19 disease - a systematic review 100
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin 100
Editorial: Dysmetabolism, obesity, and inflammation: Three prominent actors in the drama of major neuropsychiatric disorders 99
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. 98
The effects of oleoylethanolamide on feeding behaviour involve hypothalamic oxytocin neurons 98
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 98
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 98
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease 97
The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: An in vivo microdialysis study in the awake rat 97
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 96
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease 94
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 94
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 94
Neurochemical changes produced by CHF2819, a novel, orally active acetylcholinesterase inhibitor, in rat brain 93
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 93
The Role of Toll-Like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 92
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 89
Insulin signaling: An opportunistic target to minify risk of Alzheimer's disease 88
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus 88
Effects of ENA713 and CHF2819, two anti-Alzheimer’s disease drugs, on rat amino acid levels 85
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats 85
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 83
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice 83
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 82
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 80
Totale 12.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022474 0 11 4 8 39 14 12 38 89 76 30 153
2022/20232.350 202 96 96 158 115 230 39 194 1.104 23 46 47
2023/2024472 61 32 17 23 46 157 21 11 2 11 2 89
2024/20251.916 85 19 79 64 72 234 231 95 468 151 213 205
2025/20263.898 246 304 510 511 259 153 761 405 282 229 85 153
2026/2027285 73 212 0 0 0 0 0 0 0 0 0 0
Totale 13.177